Buckle upPosted by: Katherine Hargreaves 12th April 2016 Valeant Pharmaceuticals Intl Inc with TICKER NYSE:VRX had its stock rating noted as ‘Reiterated’ with the recommendation being set at ‘BUY’ yesterday by analysts at Rodman & Renshaw. Valeant Pharmaceuticals Intl Inc are listed in the Health Care sector within NYSE. Rodman & Renshaw have set a target price of 105 USD on its stock. This would imply the analyst believes there is a potential upside of 205.5% from the opening price of 34.37 USD.
Valeant Pharmaceuticals Intl Inc NYSE:VRX has a 50 day moving average of 64.73 USD and the 200 Day Moving Average price is recorded at 140.87 USD. The 1 year high for the stock price is 263.81 USD while the year low stock price is currently 25.27 USD. Over the last 30 and 90 trading days the company share price has decreased 42.15 points and decreased 59.71 points respectively. There are currently 324,519,009 shares in issue with the average daily volume traded being 36,358,121. Market capitalisation for NYSE:VRX is $10,666,939,479.00 USD.